
Focusing on prevention is fine, but given India’s massive burden of premature deaths and disability, mere 10.2% increase in MoHFW’s…
Focusing on prevention is fine, but given India’s massive burden of premature deaths and disability, mere 10.2% increase in MoHFW’s…
The pharmaceutical Sector in India is at the crossroads. Having established itself as the world leader in the space of…
The government has done well to think about door-to-door screening for cancer, heart disorders and diabetes given the rise in…
The first step is to admit the health challenges. Only then will we start thinking of ways to address them
The country is in dire need of both national and state level medical commissions
We need to prioritise public health allocations and reduce budgetary inefficiencies
Much before the Union Budget was unveiled, Indian pharmaceutical and medical device manufacturers were granted significant competitive privileges over their…